A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes med ...

The government has suggested weight-loss drugs could boost the economy by helping obese people in England get back to work.But NHS experts have warned treatment services are already overstretched ...

Dwight Burdick, MD, was a private physician to the Saudi royal family for 20 years, serving on King Abdullah bin Abdulaziz Al ...

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...

Providing coverage for weight-loss drugs such as Wegovy and Ozempic is forcing employers to make some critical decisions.

New weight-loss jabs could help boost the economy in Britain by getting people “back into work”, the Prime Minister has said.

A study by Health Innovation Manchester and Lilly will examine the “real-world effectiveness” of anti-obesity treatment ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.

Currently the use of jabs such as Wegovy for weight loss, which is also licensed as Ozempic for treatment ... Both Wegovy and Mounjaro injections are licensed for obese adults and for those ...

Bunnie XO's weight loss journey ... the name Mounjaro or Zepbound, though Bunnie did not specify if she was using either brand. Like semaglutide—the drug behind Ozempic and Wegovy—tirzepatide ...